Reduction of FGFR1-targeting miRNAs for cancer therapy deteriorate diabetes and cardiac functions, because the FGFR1-PI3K-AKT signaling cascade is involved in cancer promotion (Katoh et al., 2013c) as well as diabetes control (Suh et al., 2014). The gene discussed is AKT1; the disease is diabetes mellitus.